Mabqi & Abzena – Your Integrated Antibody Discovery Through Development Solution
Mabqi & Abzena established a partnership to integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution.
The partnership’s combined offerings will leverage Mabqi’s LiteMab© Antibody Discovery Studio for hit screening, characterization, and hit selection by using universal & pH-sensitive libraries to identify top lead candidates, and take advantage of Abzena’s capabilities for developability, cell line development, process development, and GMP manufacturing.
Access our brochure to discover how we can seamlessly advance your program to IND and beyond.
